Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nele Laudus"'
Autor:
Nynke Willers, Patrick Neven, Giuseppe Floris, Cecile Colpaert, Eva Oldenburger, Sileny Han, Chantal Van Ongeval, Ann Smeets, Francois P. Duhoux, Hans Wildiers, Petra Denolf, Nele Laudus, Els Dequeker, Isabel De Brabander, Nancy Van Damme, Harlinde De Schutter
Publikováno v:
Clinical Breast Cancer. 23:e273-e280
Autor:
Inne Nauwelaers, Nele Laudus, Dieter Peeters, Balazs Acs, Carsten Denkert, Stefan Michiels, Hugo Horlings, Kalliopi P. Siziopikou, Scott Ely, Dimitrios Zardavas, Roberts Mustimbo, John Bartlett, Giuseppe Floris, Johan Hartman, Carolien H. M. van Deurzen, Dorien Ceusters, Els Dequeker, Roberto Salgado
Publikováno v:
Cancers, 14(15):3762. Multidisciplinary Digital Publishing Institute (MDPI)
New assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltr
Publikováno v:
Cancers. 14(15)
External quality assessment (EQA) schemes are a tool for clinical laboratories to evaluate and manage the quality of laboratory practice with the support of an independent party (i.e., an EQA provider). Depending on the context, there are different t
Autor:
Carolien H M van Deurzen, Stefan Michiels, Roberto Salgado, M. Brinkhuis, Marleen Kok, Iris Nederlof, Dieter Peeters, Fabiola Giudici, Els Dequeker, John M. S. Bartlett, Mustimbo Roberts, Scott Ely, Pieter J. Westenend, Celine Vreuls, Mieke R Van Bockstal, Maxine Cooks, David L. Rimm, Hugo M. Horlings, Inne Nauwelaers, Loes F. S. Kooreman, Dimitrios Zardavas, Bert van der Vegt, Annemiek C. Dutman, Kalliopi P. Siziopikou, L.C. Verhoog, Carsten Denkert, Giuseppe Floris, Paul J. van Diest, Monique Koopmans, Balazs Acs, Nele Laudus, Johan Hartman
Publikováno v:
Cancers, 13(19):4910. MDPI AG
Cancers
Cancers, Vol 13, Iss 4910, p 4910 (2021)
Van Bockstal, M R, Cooks, M, Nederlof, I, Brinkhuis, M, Dutman, A, Koopmans, M, Kooreman, L, Van Der Vegt, B, Verhoog, L, Vreuls, C, Westenend, P, Kok, M, Van Diest, P J, Nauwelaers, I, Laudus, N, Denkert, C, Rimm, D, Siziopikou, K P, Ely, S, Zardavas, D, Roberts, M, Floris, G, Hartman, J, Acs, B, Peeters, D, Bartlett, J M S, Dequeker, E, Salgado, R, Giudici, F, Michiels, S, Horlings, H & Van Deurzen, C H M 2021, ' Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group ', Cancers, vol. 13, no. 19, pp. 4910 . https://doi.org/10.3390/cancers13194910, https://doi.org/10.3390/cancers13194910
Cancers, Vol. 13, no. 19, p. 4910 [1-20] (2021)
Cancers, 13(19):4910. Multidisciplinary Digital Publishing Institute (MDPI)
Volume 13
Issue 19
Cancers
Cancers, Vol 13, Iss 4910, p 4910 (2021)
Van Bockstal, M R, Cooks, M, Nederlof, I, Brinkhuis, M, Dutman, A, Koopmans, M, Kooreman, L, Van Der Vegt, B, Verhoog, L, Vreuls, C, Westenend, P, Kok, M, Van Diest, P J, Nauwelaers, I, Laudus, N, Denkert, C, Rimm, D, Siziopikou, K P, Ely, S, Zardavas, D, Roberts, M, Floris, G, Hartman, J, Acs, B, Peeters, D, Bartlett, J M S, Dequeker, E, Salgado, R, Giudici, F, Michiels, S, Horlings, H & Van Deurzen, C H M 2021, ' Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group ', Cancers, vol. 13, no. 19, pp. 4910 . https://doi.org/10.3390/cancers13194910, https://doi.org/10.3390/cancers13194910
Cancers, Vol. 13, no. 19, p. 4910 [1-20] (2021)
Cancers, 13(19):4910. Multidisciplinary Digital Publishing Institute (MDPI)
Volume 13
Issue 19
Simple Summary: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that lacks significant expression of estrogen receptor, progesterone receptor, and HER2. Patients with locally advanced or metastatic TNBC benefit from treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::110e200d33650dfbd0c601a89f230a75
https://research.rug.nl/en/publications/ac14eec3-150e-4afb-854b-dc6bbd121f3c
https://research.rug.nl/en/publications/ac14eec3-150e-4afb-854b-dc6bbd121f3c
Autor:
Nele Laudus, Heike Torkler, E. Girodon, Elisabeth Dequeker, Dragica Radojkovic, Marie Pierre Audrézet, Raina Yamamoto, Manuela Seia, Michael Morris, C. Raynal, A. Stambergova
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 19(6)
BACKGROUND: The clinical spectrum associated with cystic fibrosis transmembrane conductance regulator (CFTR) variant p.Arg117His is highly variable, ranging from full-blown cystic fibrosis (CF) in a small number of cases to CFTR-related disorders (CF